Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Kurt Davies, PhD, Instructor with the University of Colorado Health Sciences Center – Department of Pharmacology, and Nirali Patel MD, Assistant Professor, Department of Pathology and Laboratory Medicine, UNC School of Medicine join GRACE to discuss Molecular Diagnostic Testing and Next Generation Sequencing. This extremely informative (audio only) webinar series discusses cancer cell biology, targeted therapies, genetic testing, the importance of retesting in cases of resistance, and next generation sequencing.
Cancer Cell Biology 101, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
How Targeted Therapies Treat Cancer, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
How it Works: Genetic Testing in Lung Cancer, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
Resistance to Targeted Therapies, and the Importance of Retesting, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
What is Next Generation Sequencing (NGS)? Presented by Nirali Patel MD, Assistant Professor, Department of Pathology and Laboratory Medicine, UNC School of Medicine
GRACE would like to thank the following sponsors for their support of this program
![]()

Please feel free to offer comments and raise questions in our
discussion forums.
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: